The Moscow Times on MSNOpinion
Tatyana Rybakova: Russia's Self-Imposed Isolation Reaches a New Frontier: Medicine
There are two contrasting opinions about Russia’s pharmaceutical market. A common sight on Russian-speaking forums across ...
ESMO 2025 showcased the breadth and urgency of breast cancer research, which remains one of the most diagnosed malignancies ...
Dosage for Mestinon depends on the form you’re prescribed and the severity of your myasthenia gravis. The drug comes as a liquid solution, tablet, and extended-release tablet. Your doctor will likely ...
Karyopharm Therapeutics Inc. , a commercial-stage pharmaceutical company pioneering novel cancer therapies, today reported financial results for the third quarter ended September 30, 2025 and ...
- Top-Line Data from the Phase 3 SENTRY Trial in Myelofibrosis on Track for March 2026 - - Total Revenue was $44.0 Million; U.S. XPOVIO® (selinexor) Net Product Revenue was $32.0 Million, an increase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback